Atossa Genetics Stock Market Outlook
| ATOS Stock | USD 4.82 0.17 3.41% |
Slightly above 61% of all Atossa Genetics' private investors are looking to take a long position. The analysis of overall sentiment of trading Atossa Genetics stock suggests that some investors are interested at this time. Atossa Genetics' investing sentiment can be driven by a variety of factors including economic data, Atossa Genetics' earnings reports, geopolitical events, and overall market trends.
Comfort Level 61
Interested
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Atossa Genetics' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Atossa Genetics.
News SentimentBullish | Hype SentimentBearish | Insider SentimentAcquiring |
Given the investment horizon of 90 days and your highly speculative risk level, our recommendation regarding Atossa Genetics is 'Hold'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Atossa Genetics given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Atossa Genetics, the advice is generated through an automated system that utilizes algorithms and statistical models.
Execute Atossa Genetics Advice
The Atossa recommendation should be used to complement the investment advice compiled from the current analysts' consensus on Atossa Genetics. Macroaxis does not own or have any residual interests in Atossa Genetics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Atossa Genetics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Weakest | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Small | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
For the selected time horizon Atossa Genetics has a Risk Adjusted Performance of (0.16), Jensen Alpha of (1.30), Total Risk Alpha of (1.84) and Treynor Ratio of (1.53)We provide trade advice to complement the prevailing expert consensus on Atossa Genetics. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Atossa Genetics is not overpriced, please confirm all Atossa Genetics fundamentals, including its book value per share, and the relationship between the net income and number of employees . Given that Atossa Genetics has a price to earning of (0.62) X, we suggest you to validate Atossa Genetics market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.
Atossa Genetics Trading Alerts and Improvement Suggestions
| Atossa Genetics generated a negative expected return over the last 90 days | |
| Atossa Genetics has high historical volatility and very poor performance | |
| Net Loss for the year was (25.5 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Atossa Genetics currently holds about 125.54 M in cash with (21.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.99. | |
| Atossa Genetics has a frail financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: We Think Atossa Therapeutics Needs To Drive Business Growth Carefully |
Atossa Genetics Returns Distribution Density
The distribution of Atossa Genetics' historical returns is an attempt to chart the uncertainty of Atossa Genetics' future price movements. The chart of the probability distribution of Atossa Genetics daily returns describes the distribution of returns around its average expected value. We use Atossa Genetics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Atossa Genetics returns is essential to provide solid investment analysis for Atossa Genetics.
| Mean Return | -1.23 | Value At Risk | -8.77 | Potential Upside | 6.75 | Standard Deviation | 5.88 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Atossa Genetics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Atossa Stock Institutional Investors
The Atossa Genetics' institutional investors refer to entities that pool money to purchase Atossa Genetics' securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Goldman Sachs Group Inc | 2025-06-30 | 335 K | Susquehanna International Group, Llp | 2025-06-30 | 273.9 K | Northern Trust Corp | 2025-06-30 | 263.4 K | Connor Clark & Lunn Inv Mgmt Ltd | 2025-06-30 | 198.7 K | Squarepoint Ops Llc | 2025-06-30 | 181.1 K | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 160.9 K | Aster Capital Management (difc) Ltd | 2025-06-30 | 144.9 K | Jain Global Llc | 2025-06-30 | 123.1 K | Bank Of America Corp | 2025-06-30 | 99.6 K | Vanguard Group Inc | 2025-06-30 | 5.8 M | Ameriprise Financial Inc | 2025-06-30 | 3 M |
Atossa Genetics Cash Flow Accounts
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Change In Cash | 96.8M | (25.5M) | (22.4M) | (17.4M) | (20.0M) | (19.0M) | |
| Free Cash Flow | (16.5M) | (20.8M) | (21.0M) | (21.0M) | (18.9M) | (18.0M) | |
| Other Non Cash Items | 5.6M | 3K | 3.0M | 1.7M | 2.0M | 1.2M | |
| Capital Expenditures | 9K | 27K | 14K | 19K | 17.1K | 16.2K | |
| Net Income | (20.6M) | (27.0M) | (30.1M) | (25.5M) | (23.0M) | (21.8M) | |
| End Period Cash Flow | 136.5M | 111M | 88.6M | 71.2M | 81.9M | 86.0M | |
| Change To Inventory | 437K | (329K) | 2.5M | (611K) | (702.7K) | (667.5K) | |
| Depreciation | 46.5K | 23K | 8K | 17K | 15.3K | 14.5K | |
| Change To Netincome | 7.1M | 6.3M | 5.3M | 6.8M | 7.8M | 8.2M | |
| Investments | (9K) | (4.7M) | (2.0M) | (19K) | (17.1K) | (18.0K) |
Atossa Genetics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Atossa Genetics or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Atossa Genetics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Atossa stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -1.3 | |
β | Beta against Dow Jones | 0.81 | |
σ | Overall volatility | 6.15 | |
Ir | Information ratio | -0.22 |
Atossa Genetics Volatility Alert
Atossa Genetics exhibits very low volatility with skewness of -2.68 and kurtosis of 14.34. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Atossa Genetics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Atossa Genetics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Atossa Genetics Fundamentals Vs Peers
Comparing Atossa Genetics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Atossa Genetics' direct or indirect competition across all of the common fundamentals between Atossa Genetics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Atossa Genetics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Atossa Genetics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Atossa Genetics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Atossa Genetics to competition |
| Fundamentals | Atossa Genetics | Peer Average |
| Return On Equity | -0.49 | -0.31 |
| Return On Asset | -0.3 | -0.14 |
| Current Valuation | (8.87 M) | 16.62 B |
| Shares Outstanding | 8.61 M | 571.82 M |
| Shares Owned By Insiders | 0.32 % | 10.09 % |
| Shares Owned By Institutions | 19.42 % | 39.21 % |
| Number Of Shares Shorted | 3.62 M | 4.71 M |
| Price To Earning | (0.62) X | 28.72 X |
| Price To Book | 0.86 X | 9.51 X |
| EBITDA | (27.6 M) | 3.9 B |
| Net Income | (25.5 M) | 570.98 M |
| Cash And Equivalents | 125.54 M | 2.7 B |
| Cash Per Share | 0.99 X | 5.01 X |
| Total Debt | 4.97 M | 5.32 B |
| Current Ratio | 35.19 X | 2.16 X |
| Book Value Per Share | 5.78 X | 1.93 K |
| Cash Flow From Operations | (21.03 M) | 971.22 M |
| Short Ratio | 2.78 X | 4.00 X |
| Earnings Per Share | (3.33) X | 3.12 X |
| Target Price | 75.0 | |
| Number Of Employees | 15 | 18.84 K |
| Beta | 1.34 | -0.15 |
| Market Capitalization | 41.51 M | 19.03 B |
| Total Asset | 76.44 M | 29.47 B |
| Retained Earnings | (211.79 M) | 9.33 B |
| Working Capital | 69.49 M | 1.48 B |
| Current Asset | 4.29 M | 9.34 B |
| Current Liabilities | 2.5 M | 7.9 B |
| Net Asset | 76.44 M |
Note: Acquisition by Quay Steven C of 2300000 shares of Atossa Genetics at 2.38 subject to Rule 16b-3 [view details]
Atossa Genetics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Atossa . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 9431.88 | |||
| Daily Balance Of Power | (0.68) | |||
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 4.93 | |||
| Day Typical Price | 4.89 | |||
| Price Action Indicator | (0.19) | |||
| Period Momentum Indicator | (0.17) |
Atossa Genetics Target Price Consensus
Atossa target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Atossa Genetics' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 4 | Strong Buy |
Most Atossa analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Atossa stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Atossa Genetics, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationAtossa Genetics Target Price Projection
Atossa Genetics' current and average target prices are 4.82 and 75.00, respectively. The current price of Atossa Genetics is the price at which Atossa Genetics is currently trading. On the other hand, Atossa Genetics' target price is what analysts think the stock is worth. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Atossa Genetics Market Quote on 11th of February 2026
Target Price
Analyst Consensus On Atossa Genetics Target Price
Atossa Genetics Analyst Ratings
Atossa Genetics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Atossa Genetics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Atossa Genetics' financials, market performance, and future outlook by experienced professionals. Atossa Genetics' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
About Atossa Genetics Buy or Sell Advice
When is the right time to buy or sell Atossa Genetics? Buying financial instruments such as Atossa Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Atossa Genetics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Data Storage Thematic Idea Now
Data Storage
Companies making data storages or providing data storage services. The Data Storage theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Data Storage Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Atossa Stock Analysis
When running Atossa Genetics' price analysis, check to measure Atossa Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Genetics is operating at the current time. Most of Atossa Genetics' value examination focuses on studying past and present price action to predict the probability of Atossa Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Genetics' price. Additionally, you may evaluate how the addition of Atossa Genetics to your portfolios can decrease your overall portfolio volatility.